Cardiovascular disease kills more women in the United States than all cancers combined. That is not a new statistic, and the American Heart Association has spent two decades trying to shift public perception, yet surveys consistently find that most women still name breast cancer as their leading health threat. The gap between reality and awareness is itself part of why heart disease remains so lethal for women.
The biology, the presentation, and the medical response all diverge from the male-default script that shaped cardiology for most of the twentieth century. Understanding those differences is the first step toward better protection.
Symptoms that do not match the script
The canonical heart attack, crushing chest pain radiating to the left arm, does occur in women, but often alongside or replaced by symptoms that are easier to dismiss.
- Unusual fatigue in the days or weeks before the event
- Shortness of breath without exertion
- Nausea, indigestion, or upper-abdominal pain
- Pain in the jaw, neck, upper back, or between the shoulder blades
- Lightheadedness or a cold sweat
Women are more likely than men to delay seeking care and more likely, on arrival, to have their symptoms attributed to anxiety or reflux. Studies in emergency settings have repeatedly shown longer time-to-treatment for women with acute coronary syndrome, particularly women under fifty-five.
Risks the traditional model missed
Standard cardiovascular risk calculators were built largely from data on middle-aged men. They capture blood pressure, cholesterol, diabetes, smoking, and age, but they undercount several factors that carry particular weight for women.
- Pregnancy complications. Preeclampsia, gestational hypertension, gestational diabetes, and preterm delivery are now recognized by the American College of Obstetricians and Gynecologists as markers of elevated long-term cardiovascular risk, sometimes by decades.
- Early menopause. Menopause before age forty-five is associated with higher rates of coronary events, likely reflecting the loss of estrogen's protective effects on vessels and lipids.
- Autoimmune disease. Conditions such as lupus and rheumatoid arthritis, both far more common in women, carry accelerated atherosclerosis independent of traditional risk factors.
- Polycystic ovary syndrome. Associated with insulin resistance, dyslipidemia, and higher long-term cardiometabolic risk.
A thorough cardiovascular history in a woman should therefore include her obstetric history, her menstrual and menopausal timeline, and any autoimmune diagnoses. Many still do not.
Small vessels, missed diagnoses
Women are more likely than men to have coronary microvascular disease and spontaneous coronary artery dissection, both of which can produce ischemia and infarction without the classic obstructive plaque that a standard angiogram is designed to find. When a woman presents with chest pain and her angiogram is read as clean, the story is not always over. Persistent symptoms deserve further evaluation, not reassurance alone.
A normal angiogram rules out one kind of heart disease. It does not rule out heart disease.
What actually moves risk
The interventions with the largest evidence base are the least glamorous. Blood pressure control, lipid management when indicated, not smoking, adequate physical activity, sleep, and treatment of diabetes together account for the majority of preventable cardiovascular events. Statins, aspirin in specific circumstances, and newer agents like GLP-1 receptor agonists have shifted the landscape further, though decisions about each should be individualized with a clinician who knows your full history.
Menopausal hormone therapy is not a cardiovascular preventive. The North American Menopause Society is explicit on this point: hormone therapy has a role in managing menopausal symptoms in appropriate candidates, but it is not prescribed to prevent heart disease.
The bottom line
Heart disease is the leading cause of death for women, and the reasons it goes underdiagnosed are structural, not accidental. Know the atypical symptoms, ask your clinician to consider pregnancy history and menopausal timing as part of your risk profile, and treat blood pressure, lipids, and metabolic health seriously well before you feel any effects. The interventions that work are known. The gap is in applying them to women with the same rigor they have long received.